151 related articles for article (PubMed ID: 30820346)
1. Activation of TAp73 and inhibition of TrxR by Verteporfin for improved cancer therapy in
Acedo P; Fernandes A; Zawacka-Pankau J
Future Sci OA; 2019 Feb; 5(2):FSO366. PubMed ID: 30820346
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in
Sznarkowska A; Kostecka A; Kawiak A; Acedo P; Lion M; Inga A; Zawacka-Pankau J
Cell Div; 2018; 13():10. PubMed ID: 30603043
[TBL] [Abstract][Full Text] [Related]
3. Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells.
Jiang L; Malik N; Acedo P; Zawacka-Pankau J
Cell Death Discov; 2019; 5():77. PubMed ID: 30886745
[TBL] [Abstract][Full Text] [Related]
4. JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress.
Kostecka A; Sznarkowska A; Meller K; Acedo P; Shi Y; Mohammad Sakil HA; Kawiak A; Lion M; Królicka A; Wilhelm M; Inga A; Zawacka-Pankau J
Cell Death Dis; 2014 Oct; 5(10):e1484. PubMed ID: 25341038
[TBL] [Abstract][Full Text] [Related]
5. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma.
Thakur AK; Nigri J; Lac S; Leca J; Bressy C; Berthezene P; Bartholin L; Chan P; Calvo E; Iovanna JL; Vasseur S; Guillaumond F; Tomasini R
Cell Death Differ; 2016 Aug; 23(8):1358-70. PubMed ID: 26943320
[TBL] [Abstract][Full Text] [Related]
6. The Undervalued Avenue to Reinstate Tumor Suppressor Functionality of the p53 Protein Family for Improved Cancer Therapy-Drug Repurposing.
Zawacka-Pankau JE
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32971841
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy of vertebral metastases: evaluating tumor-to-neural tissue uptake of BPD-MA and ALA-PpIX in a murine model of metastatic human breast carcinoma.
Akens MK; Yee AJ; Wilson BC; Burch S; Johnson CL; Lilge L; Bisland SK
Photochem Photobiol; 2007; 83(5):1034-9. PubMed ID: 17880497
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative.
Simkin GO; King DE; Levy JG; Chan AH; Hunt DW
Immunopharmacology; 1997 Oct; 37(2-3):221-30. PubMed ID: 9403341
[TBL] [Abstract][Full Text] [Related]
9. Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death.
Nakamura M; Sugimoto H; Ogata T; Hiraoka K; Yoda H; Sang M; Sang M; Zhu Y; Yu M; Shimozato O; Ozaki T
Oncogenesis; 2016 Jun; 5(6):e233. PubMed ID: 27294865
[TBL] [Abstract][Full Text] [Related]
10. Verteporfin mediated sequence dependent combination therapy against ovarian cancer cell line.
Erdem SS; Obeidin VA; Yigitbasi T; Tumer SS; Yigit P
J Photochem Photobiol B; 2018 Jun; 183():266-274. PubMed ID: 29747146
[TBL] [Abstract][Full Text] [Related]
11. Comparison of protoporphyrin IX produced cell proliferation inhibition between human breast cancer MCF-7 and MDA-MB-231 cells.
Li L; Chen Y; Wang X; Feng X; Wang P; Liu Q
Pharmazie; 2014 Aug; 69(8):621-8. PubMed ID: 25158574
[TBL] [Abstract][Full Text] [Related]
12. New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma.
Gomes S; Raimundo L; Soares J; Loureiro JB; Leão M; Ramos H; Monteiro MN; Lemos A; Moreira J; Pinto M; Chlapek P; Veselska R; Sousa E; Saraiva L
Cancer Lett; 2019 Apr; 446():90-102. PubMed ID: 30664963
[TBL] [Abstract][Full Text] [Related]
13. Protoporphyrin IX-mediated sonodynamic action induces apoptosis of K562 cells.
Su X; Li Y; Wang P; Wang X; Liu Q
Ultrasonics; 2014 Jan; 54(1):275-84. PubMed ID: 23978616
[TBL] [Abstract][Full Text] [Related]
14. Protoporphyrin IX interacts with wild-type p53 protein in vitro and induces cell death of human colon cancer cells in a p53-dependent and -independent manner.
Zawacka-Pankau J; Issaeva N; Hossain S; Pramanik A; Selivanova G; Podhajska AJ
J Biol Chem; 2007 Jan; 282(4):2466-72. PubMed ID: 17135250
[TBL] [Abstract][Full Text] [Related]
15. In vitro photosensitisation of a murine mammary adenocarcinoma cell line with Verteporfin.
Casas A; Di Venosa G; Batlle A; Fukuda H
Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):931-7. PubMed ID: 12699253
[TBL] [Abstract][Full Text] [Related]
16. Curcumin induces apoptosis in p53-null Hep3B cells through a TAp73/DNp73-dependent pathway.
Wang J; Xie H; Gao F; Zhao T; Yang H; Kang B
Tumour Biol; 2016 Mar; 37(3):4203-12. PubMed ID: 26490992
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of singlet oxygen explicit dosimetry for predicting treatment outcomes of benzoporphyrin derivative monoacid ring A-mediated photodynamic therapy.
Kim MM; Penjweini R; Zhu TC
J Biomed Opt; 2017 Feb; 22(2):28002. PubMed ID: 28301655
[TBL] [Abstract][Full Text] [Related]
18. Distribution of photosensitizers in bladder cancer spheroids: implications for intravesical instillation of photosensitizers for photodynamic therapy of bladder cancer.
Xiao Z; Hansen CB; Allen TM; Miller GG; Moore RB
J Pharm Pharm Sci; 2005 Sep; 8(3):536-43. PubMed ID: 16401399
[TBL] [Abstract][Full Text] [Related]
19. RIP kinase-mediated ROS production triggers XAF1 expression through activation of TAp73 in casticin-treated bladder cancer cells.
Chung YH; Kim D
Oncol Rep; 2016 Aug; 36(2):1135-42. PubMed ID: 27349281
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of antivascular photodynamic therapy using benzoporphyrin derivative monoacid ring A (BPD-MA) in 14 dogs with oral and nasal tumors.
Osaki T; Takagi S; Hoshino Y; Okumura M; Kadosawa T; Fujinaga T
J Vet Med Sci; 2009 Feb; 71(2):125-32. PubMed ID: 19262021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
